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Abstract
Introduction The enhanced recovery after surgery (ERAS) protocol, which emphasizes preoperative interventions, is safely
implemented in patients undergoing bariatric surgery. Patients are additionally encouraged to achieve weight loss preoperatively.
We aimed to identify factors contributing to preoperative weight loss and assess their influence on outcomes of bariatric surgery
among patients under the ERAS protocol.
Materials and Methods We reviewed a prospectively created database in two bariatric centers with 909 bariatric patients treated
in accordance with ERAS principles. The database included demographic characteristics, factors related to the surgery or
perioperative period, and short-term outcomes. Our endpoints included analyses of (1) factors potentially contributing to preop-
erative weight loss and (2) the influence of preoperative weight loss on short-term outcomes of bariatric treatment.
Results Diabetes mellitus (p = 0.007), obstructive sleep apnea (p < 0.001), and previous surgery (p = 0.012) were identified as
predictors of preoperative weight loss. Steatohepatitis (p < 0.001) and respiratory disorder (p = 0.004) decreased the chance of
achieving satisfactory preoperative body mass reduction. Except for operative time, early outcomes of bariatric surgery were not
influenced by preoperative weight loss. Patients who achieved preoperative weight loss were less likely to be lost to follow-up
(p = 0.023). Postoperative weight loss was better in patients who could lose ≥ 5% total weight preoperatively (p = 0.009).
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Conclusion Unsatisfactory preoperative weight loss among patients treated under ERAS principles is not associated with in-
creased risk of complications. Satisfactory preoperative weight loss predicts superior postoperative weight loss and follow-up
participation.
Keywords Obesity . Bariatric surgery . Preoperative weight loss . Perioperative care . ERAS . Sleeve gastrectomy . Gastric
bypass . Outcomes
Introduction
Laparoscopic sleeve gastrectomy (LSG) and laparoscopic
Roux-en-Y gastric bypass (LRYGB) are currently the most
commonly performed bariatric procedures [1–3].
Improvement in the outcomes may be expected with imple-
mentation of a structured system ofmodern perioperative care.
The enhanced recovery after surgery (ERAS) protocol or other
fast-track approaches have been safely implemented in many
bariatric centers [4]. The ERAS protocol designed for bariatric
surgery emphasizes extensive preoperative interventions, in-
cluding medical, educational, dietary, and psychological [5,
6]. The structured program of perioperative care allows dis-
charge from the hospital as soon as patients achieve functional
recovery, thereby reducing the length of hospital stay with no
influence on postoperative morbidity [7]. The overall compli-
ance rate with components of the ERAS protocol is an essen-
tial factor contributing to the beneficial impact on surgical
outcomes [8, 9].
Even though weight loss is not a classic requirement of the
ERAS protocol, bariatric patients are usually encouraged to
achieve at least some reduction in their body mass before
surgery because it is believed to influence results [10]. Data
concerning the role of preoperative weight loss as an indepen-
dent factor for bariatric patients (undergoing LSG or LRYGB)
are so far inconclusive. Moreover, we were unable to find any
study that had evaluated this factor in patients whose periop-
erative care was based on ERAS principles.
Our objective was to identify potential factors contributing
to preoperative weight loss. We also aimed to investigate the
influence of preoperative weight loss on short-term outcomes
of LSG and LRYGB among patients under the ERAS protocol.
Materials and Methods
Study Design
We reviewed a prospectively created database. Data concerning
patients operated on in two tertiary referral bariatric centers
between 2012 and 2017 were collected by the authors directly
involved in the treatment. Qualification for bariatric surgery
was based on recommendations of the Metabolic and
Bariatric Surgery Chapter of the Polish Surgical Society.
Inclusion criteria for this study were informed consent to par-
ticipate in the study, meeting the eligibility criteria for bariatric
treatment [body mass index (BMI) ≥ 35 kg/m2 with obesity-
related comorbidities orBMI ≥ 40 kg/m2], and qualification for
LSG or LRYGB. We excluded patients with insufficient data
on coexisting ailments and those who had undergone revision
surgery. Patients were not excluded from the study group, if
they did not achieve a certain preoperative weight loss. The
study was designed, and the results described, according to all
STROBE checklist points for observational studies.
The database included demographic characteristics, fac-
tors related to the surgery or perioperative period, and short-
term outcomes. Patients’ baseline characteristics included
preoperative weight loss, age, sex, maximum preoperative
BMI, BMI on the day of operation, American Society of
Anesthesiologists physical status class, type of bariatric op-
eration (LSG or LRYGB), comorbidities (diabetes mellitus,
steatohepatitis, hypertension, dyslipidemia, cardiological
disorders, respiratory disorders (asthma and chronic obstruc-
tive pulmonary disease), obstructive sleep apnea), and previ-
ous surgeries. Perioperative variables included the LSG or
LRYGB operative time, intraoperative adverse events, con-
versions, postoperative complications (according to the
Clavien–Dindo classification)—paying special attention to
gastrointestinal leakage, gastrointestinal stricture, rhabdo-
myolysis, postoperative hemorrhage, wound infection, mar-
ginal ulcers, port-site hernia, abscess—reoperations, length
of hospital stay (LOS), and readmissions. Outcomes of bar-
iatric treatment were evaluated 6 months after the surgery,
with the follow-up examination including measurement of




ed into two groups: group 1 (preoperative weight loss < 5%
totalbodyweight)andgroup2(preoperativeweightloss≥ 5%
total body weight). The cutoff point for preoperative weight
loss of 5%was based on a report byGiordano andVictorzon,
who defined it as (1) achievable by a high rate of patients; (2)
associated with reduced operative time, hospital stays, and
overall morbidity; and (3) associated with evidence of posi-
tive bariatric surgery results [11].Wealso analyzed the corre-
lation of preoperative weight loss as a continuous variable
with bariatric surgery-associated postoperativeweight loss.
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An intraoperative adverse event was defined as any iatro-
genic harmful event not derived from the standard LSG or
LRYGB technique. Postoperative complications were defined
as adverse events occurring within 30 days after the procedure
and were categorized (according to the Clavien–Dindo classi-
fication)) as minor (grade I, II) or major (III, IV, V).
Rhabdomyolysis was defined as elevated creatinine phospho-
kinase (> 1000 IU/l) with coexisting increased myoglobin.
Gastrointestinal leakage was diagnosed clinically and con-
firmed radiologically. Postoperative hemorrhage was defined
as a significant drop in hemoglobin that required reoperation
or transfusion with packed red blood cells.
Treatment Protocol and Surgical Techniques
To minimize bias, patients were treated in accordance with the
ERAS pathway—i.e., preoperatively, intraoperatively, post-
operatively (Supplement 1). The perioperative care protocol
is described in detail in our previous publications [4–6]. The
LSG and LRYGB surgical techniques used at our centers were
also thoroughly described previously [7, 12].
Measured Outcomes
The primary endpoints comprised analysis of potential factors




& Comorbidities (diabetes mellitus, steatohepatitis, hyper-
tension, dyslipidemia, cardiovascular disorders, respirato-
ry disorders, obstructive sleep apnea)
& Previous surgeries
The secondary endpoints derived from the analysis of the
association between preoperative weight loss and short-term
outcomes of LSG and LRYGB, including:
& Operative time





& Percentage of patients lost to follow-up
& Absolute weight loss





Statistical data were calculated using a spreadsheet and
StatSoft STATISTICA version 12 (StatSoft Inc., Tulsa, OK,
USA). For testing categorical variables, the 휒2 test of inde-
pendence was applied. The Shapiro–Wilk test was used to test
the normal distribution of data. The results are presented as
medians and interquartile range (IQR) for non-normally dis-
tributed values. A non-parametric Mann–Whitney U test was
used to compare non-normally distributed data. Univariate
and multivariate logistic regression analysis for preoperative
weight loss ≥ 5% was performed to assess the influence of
selected baseline characteristics. We also addressed the influ-
ence of preoperative weight loss ≥ 5% on intraoperative ad-
verse events, postoperative complications, gastrointestinal
leakage, gastrointestinal stricture, rhabdomyolysis, postopera-
tive hemorrhage, wound infection, port-site hernia, abscess
formation, reoperation, and readmission using univariate lo-
gistic regression models. Pearson’s test was used to verify the
correlation between preoperative weight loss and %TWL,
%EWL, and %EBMIL. Results were considered statistically
significant at p < 0.05.
Results
The average preoperative weight loss in our study group of
909 patients was 4.89%. Overall, 560 patients (61.61%) were
included in group 1 and 349 patients (38.39%) in group 2.
There were more men than women in group 1 (35.54% vs.
28.08%, p = 0.019). Although the medianmaximumBMIwas
comparable in groups 1 and 2 (45.65 vs. 46.06, p = 0.263), the
median preoperative BMI was significantly higher in group 1
(45.17 vs. 41.14, p < 0.001). Diabetes mellitus and obstructive
sleep apnea were more likely to be diagnosed in group 2
patients (29.11% vs. 36.1%, p = 0.027 and 5.36% vs.
10.03%, p = 0.007, respectively), whereas steatohepatitis
was more commonly diagnosed in group 1 patients (64.82%
vs. 50.14%, p < 0.001). Patients who underwent previous sur-
gery were more common in group 2 (45.54% vs. 56.16%, p =
0.002). Additional preoperative study group characteristics
are presented in Table 1. Patients’ flow throughout the study
is presented in Fig. 1.
Primary Endpoints
Univariate logistic regression analysis revealed that high max-
imum BMI (OR 1.02, 95% CI 1.00–1.04, p = 0.048), diabetes
mellitus (OR 1.38, 95% CI 1.04–1.83, p = 0.027), obstructive
sleep apnea (OR 1.97, 95% CI 1.19–3.27, p = 0.009), and
previous surgery (OR 1.53, 95% CI 1.17–2.01, p = 0.002)
were related to increased chance of achieving preoperative
weight loss of ≥ 5%, whereas male sex [odds ratio (OR)
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Table 1 Patient baseline
characteristics Parameter Group 1 Group 2 p value
Patients, n 560 349
61.61% 38.39%
Mean preoperative weight loss, %TWL SD 1.10% (0–2.87%) 8.62% (6.67–12.62%)
Median age, years IQR 43 (35–51) 42 (35–50) 0.343
Sex/number of males, n 199 98 0.019
35.54% 28.08%
Median maximal BMI, kg/m2 IQR 45.65 (41.99–50.34) 46.06 (42.02–51.72) 0.263
Median preoperative BMI, kg/m2 IQR 45.17 (41.43–49.64) 41.14 (37.48–45.73) < 0.001






Surgery/number of LSG, n 183 102 0.274
32.68% 29.23%
Comorbidities, n 479 288 0.226
85.54% 82.52%
Diabetes mellitus, n 163 126 0.027
29.11% 36.1%
Steatohepatitis, n 363 175 < 0.001
64.82% 50.14%
Hypertension, n 361 226 0.839
64.46% 64.76%
Dyslipidemia, n 313 187 0.488
55.89% 53.58%
Cardiovascular disorders, n 77 57 0.291
13.75% 16.33%
Respiratory disorders, n 88 43 0.162
15.71% 12.32%
Obstructive sleep apnea, n 30 35 0.007
5.36% 10.03%
Previous surgeries, n 255 196 0.002
45.54% 56.16%
Italic data statistically significant result
Fig. 1 Flowchart
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0.71, 95% confidence interval (CI) 0.53–0.95, p = 0.020] and
steatohepatitis (OR 0.55, 95% CI 0.42–0.72, p < 0.001) de-
creased it. The multivariate logistic regression model identi-
fied diabetes mellitus (OR 1.61, 95% CI 1.14–2.26, p =
0.007), obstructive sleep apnea (OR 4.02, 95% CI 2.12–
7.63, p < 0.001), and previous surgery (OR 1.49, 95% CI
1.09–2.02, p = 0.012) as positive predictors, whereas
steatohepatitis (OR 0.40, 95% CI 0.28–0.59, p < 0.001) and
respiratory disorders (OR 0.49, 95% CI 0.30–0.80, p = 0.004)
were negative predictors (Table 2).
Secondary Endpoints
The median LSG and LRYGB operative times were both sig-
nificantly longer in group 1 than in group 2 (90 vs 75 min,
p < 0.001 and 120 min vs. 100 min, p = 0.010, respectively).
The incidences of intraoperative adverse events, postoperative
complications in general, and specific postoperative complica-
tions were not significantly influenced by preoperative weight
loss. Comparison of postoperative complications (Clavien–
Dindo classification) between groups did not reveal significant
differences. The groups were also comparable in terms of reop-
eration rates, LOS, and readmission rates (Tables 3 and 4).
It seems that we observed a trend among patients in group 1 of
a slightly less frequent participation in follow-up examinations
(65.0% vs. 72.2%, p= 0.023). Themedian%TWLwas higher in
group 2 (29.96% vs. 32.41%, p = 0.009). The preoperative
weight loss correlated positively with both %TWL (R = 0.211,
p < 0.001) and %EBMIL (R = 0.1, p = 0.015) (Tables 5 and 6).
Discussion
Our multi-center study is one of the first attempts to investigate
the role of weight loss prior to bariatric treatment (LSG,
LRYGB) as part of the ERAS protocol. Patients suffering from
diabetes mellitus or obstructive sleep apnea and those with
Table 3 Impact of the PWL on perioperative outcomes of bariatric
surgery group 2 vs. group 1
Parameter Group 1 Group 2 p value
Median LSG time, min IQR 90 (70–120) 75 (55–100) < 0.001
Median LRYGB time, min IQR 120 (95–170) 100 (90–150) 0.010
Intraoperative adverse events, n 34 21 0.973
6.07% 6.02%
Conversions, n 0 0 –
Postoperative complications, n 38 25 0.839
6.81% 7.16%
Gastrointestinal stricture, n 3 1 0.579
0.54% 0.29%
Gastrointestinal stricture, n 3 1 0.579
0.54% 0.29%
Rhabdomyolysis, n 7 6 0.567
1.25% 1.72%
Postoperative hemorrhage, n 10 8 0.599
1.79% 2.29%
Wound infection, n 1 0 0.429
0.18%
Port-site hernia, n 1 0 0.429
0.18%
Abscess, n 2 1 0.854
0.36% 0.29%
Clavien–Dindo I–II, n 22 14 0.959
3.93% 4.01%
Clavien–Dindo III–V, n 16 11 0.806
2.86% 3.15%
Reoperation, n 10 4 0.433
1.79% 1.15%
Median LOS, days IQR 3 (2–5) 4 2–5 0.884
Readmission, n 30 21 0.694
5.40% 6.02%
Italic data statistically significant result
Table 2 Factors contributing to achieving the preoperative weight loss
of at least 5%—logistic regression analysis
Parameter OR 95% CI p value
Univariate
Median age 0.99 0.98–1.01 0.474
Sex/number of males 0.71 0.53–0.95 0.020
Median maximal BMI 1.02 1.00–1.04 0.048
Comorbidities 0.80 0.56–1.15 0.224
Diabetes mellitus 1.38 1.04–1.83 0.027
Steatohepatitis 0.55 0.42–0.72 < 0.001
Hypertension 1.03 0.79–1.36 0.839
Dyslipidemia 0.91 0.70–1.19 0.488
Cardiovascular disorders 1.22 0.84–1.77 0.291
Respiratory disorders 0.76 0.51–1.12 0.162
Obstructive sleep apnea 1.97 1.19–3.27 0.009
Previous surgeries 1.53 1.17–2.01 0.002
Multivariate
Median age 0.99 0.97–1.00 0.128
Sex/number of males 0.74 0.47–1.17 0.203
Median maximal BMI 1.03 0.98–1.07 0.189
Comorbidities 1.26 0.72–2.20 0.415
Diabetes mellitus 1.61 1.14–2.26 0.007
Steatohepatitis 0.40 0.28–0.59 < 0.001
Hypertension 0.90 0.60–1.34 0.587
Dyslipidemia 1.29 0.89–1.87 0.183
Cardiovascular disorders 1.55 0.99–2.42 0.415
Respiratory disorders 0.49 0.30–0.80 0.004
Obstructive sleep apnea 4.02 2.12–7.63 < 0.001
Previous surgeries 1.49 1.09–2.02 0.012
Italic data statistically significant result
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previous surgery in their medical history were more likely to
lose weight preoperatively. Although preoperative weight loss
did not influence the perioperative course, it was associated
with superior short-term bariatric surgery-related weight loss.
Currently available studies investigating the role of preopera-
tive weight loss in bariatric surgery often reported inconsistent
results, which indicated the need for further research analyzing
its influence under various circumstances [13].
The number of bariatric procedures performed yearly is
steadily increasing [2]. This constantly growing demand for
bariatric procedures yields a need to improve each aspect of
bariatric treatment, including perioperative care [14]. The pres-
ent study concentrates on preoperative weight loss. We aimed
to verify whether it is a critical factor in achieving superior
postoperative outcomes in patients undergoing perioperative
care conducted in accordance with the ERAS protocol.
In our opinion, the ERAS protocol includes all interventions
aimed at improving the effects of surgical treatment. In the case
of bariatric procedures, it is executed during both preoperative
and perioperative periods. Guidelines of ERAS Society for
bariatric surgery include the preoperative weight loss with the
Bstrong^ grade of recommendation [15]. The ERAS protocol
for bariatric patients implemented in our department includes a
recommendation for weight reduction during the preparation
for surgery as well (Supplement 1). In our experience, it is an
important element of the protocol, but particularly difficult to
execute; therefore, it is often overlooked. Nevertheless,
implementing other components included in the ERAS path-
way allows to diminish the negative impact of omitting the
preoperative weight loss, by creating a clinical setting, which
is different from traditional perioperative care.
In our opinion, identifying factors that influence the degree
of preoperative weight loss could provide new insight into the
difficulty of achieving it during implementation of the multi-
step perioperative care protocol (ERAS). Moreover, defining
factors affecting this component of the protocol could allow
for better preparation of the patients for the procedure, by
identifying ones who require more attention and more in-
volvement during implementation of preoperative recommen-
dations. In our study, groups 1 and 2 had mostly comparable
preoperative characteristics. Male patients, however, were less
likely to lose ≥ 5% total body weight prior to surgery, which is
surprising, as most studies report that men generally lose more
weight than women when enrolled in a weight-loss interven-
tion. They also maintain their weight and continue to lose
more after the intervention [16].
Diabetes mellitus and obstructive sleep apnea were more
commonly diagnosed among patients who achieved preoper-
ative weight loss of ≥ 5%. Steatohepatitis was more frequent
in group 1, which is consistent with the results of Dudekula
et al., who showed that, among patients with non-alcoholic
fatty liver disease, achieving weight loss is largely unsuccess-
ful in the clinical setting [17]. Bergh et al. reported that a high
weight-loss goal, frequent self-weighing, and being close to
Table 5 Impact of the PWL on
short-term weight-loss outcomes
of bariatric surgery
Parameter Group 1 Group 2 p value
Follow-up, n 364 252 0.023
65.00% 72.21%
Median absolute weight loss, kg IQR 39.00 (30.00–48.00) 44.50 (29.00–55.00) 0.013
Median absolute BMI loss, IQR 13.71 (10.73–16.94) 15.24 (11.00–19.07) 0.001
Median %TWL, IQR 29.96% (24.00–35.89%) 32.41% (23.81–39.13%) 0.009
Median %EWL IQR 56.13% (45.13–70.90%) 53.20% (40.60–69.27%) 0.158
Median %EBMIL IQR 66.77% (52.60–81.65%) 71.15% (55.00–82.47%) 0.092
Italic data statistically significant result
Table 4 Impact of the PWL on OR of perioperative outcomes of
bariatric surgery group 2 vs. group1
Parameter OR 95% CI p value
Intraoperative adverse events 0.99 0.57–1.74 0.973
Postoperative complications 1.06 0.63–1.79 0.827
Gastrointestinal leakage 0.96 0.62–4.05 0.960
Gastrointestinal stricture 0.53 0.60–5.15 0.587
Rhabdomyolysis 1.38 0.46–4.15 0.564
Postoperative hemorrhage 1.29 0.50–3.30 0.595
Wound infection 0.53 0.02–13.14 0.701
Port-site hernia 0.53 0.02–13.14 0.701
Abscess 0.80 0.07–8.88 0.857
Reoperation 0.64 0.20–2.05 0.450
Readmission 1.13 0.64–2.01 0.674
Table 6 Correlation between PWL and short-term weight-loss out-
comes of bariatric treatment
Parameter R df p value
Absolute weight loss 0257 581 < 0.001
Absolute BMI loss 0.266 581 < 0.001
%TWL 0.211 581 < 0.001
%EWL − 0.04 578 0.331
%EBMIL 0.1 581 0.015
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(or at) the subject’s highest lifetime weight when applying for
surgery were identified as predictors of effective preoperative
weight loss [18]. According to Altieri et al., neither the pa-
tient’s sex, insurance, psychiatric history, comorbidities, refer-
ral status, nor type of counseling had a significant effect on
weight loss before bariatric surgery [19].
Perioperative outcomes of bariatric surgery were not influ-
enced by preoperative weight loss, except for the operative times
(both LSG and LRYGB), which were higher in group 1. This
difference may be associated with higher median preoperative
BMIs in this group. Our results seem to correlate with previous-
ly published data, suggesting that the operative time for LRYGB
could be reduced by preoperative weight loss [20]. Patients un-
dergoing LSG do not seem to receive a similar benefit [21].
Previously published research shows mixed results regard-
ing complication rates being reduced by preoperative weight
loss [22–25]. We did not observe an increase in the incidence
of postoperative complications among patients who did not
achieve significant preoperative weight loss. This difference
may have resulted from the beneficial effects of the perioper-
ative care conducted in accordance with ERAS principles.
Previously published studies reporting higher rates of postop-
erative complications among patients with unsatisfactory pre-
operative weight loss included patients undergoing perioper-
ative care not based on the ERAS protocol [22, 23]. The LOS
in our study was not influenced by preoperative weight loss,
whereas Still et al. suggested that possible candidates for bar-
iatric surgery who achieved at least 5% preoperative weight
loss of body weight had a higher probability of a shorter LOS
[26].
Patients exhibiting high compliance with the ERAS proto-
col and preoperative weight loss of ≥ 5% in the present study
were more likely to continue to attend follow-up examina-
tions. It seems that compliance with both ERAS components
and follow-up examinations results in better short-term post-
operative weight-loss outcomes [27]. The most common
causes of non-adherence to the follow-up schedule after bar-
iatric surgery reported by patients included work-related prob-
lems, family-related problems, or moving from their city or
country of residence [28]. Our results show a correlation be-
tween preoperative and weight loss associated with bariatric
treatment (measured as %TWL and %EBMIL). Most avail-
able studies offer results consistent with ours, which show
significant improvement in weight-loss effect for highly com-
pliant patients who were able to lose weight preoperatively
[20, 29]. Most recent studies also report a direct correlation
between preoperative and postoperative weight loss [30, 31].
Patients who had undergone previous surgery achieved supe-
rior preoperative weight loss. This finding may be explained
by the benefit of previous experiencewith surgical care, which
might indicate that better cooperation with the doctor and
compliance with the recommendations improve the course
of postoperative care.
This study has several limitations. First, it was a non-
randomized study on a relatively small number of patients.
Hence, because of the lack of necessary data, we were not
able to compare participation in preoperative dietary and psy-
chological interventions between groups 1 and 2. Potential
bias could result from the lack of uniformity in terms of sex
category between groups. During the preparation of the man-
uscript, we conducted a comprehensive literature search,
which did not reveal evidence stating that sex category could
significantly influence the operative times of bariatric proce-
dures. However, we do not have evidence-based sources to
support that statement. We were also not able to analyze post-
operative complications occurring after discharge if patients
were not treated in the center performing the initial surgery.
Second, the influence of preoperative weight loss on allevia-
tion of obesity-related comorbidities after bariatric treatment
was not analyzed. However, we believe that the data on the
correlation between preoperative and postoperative weight
loss remains useful. Further randomized clinical trials are re-
quired to assess the benefit of the ERAS protocol and preop-
erative weight loss among bariatric patients, especially those
undergoing LSG.
Conclusion
Unsatisfactory preoperative weight loss among patients
treated in accordance with the ERAS protocol principles
is not associated with an increased risk of complica-
tions. Patients who achieve good preoperative weight
loss are more likely to be motivated to attend follow-
up examinations. Achieving preoperative weight loss of
≥ 5% allows the prediction of superior postoperative
weight loss.
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